Stroke in critically ill patients

Minerva Anestesiologica

Volumn 75, Issue 5, 2009, Pages 245-250

  Pilato, F ^a   Profice, P ^a   Dileone, M ^a   Ranieri, F ^a   Capone, F ^a   Minicuci, G ^a   Tagliente, D ^a   Florio, L ^a   Di Iorio, R ^a   Plantone, D ^a   Tonali, P A ^a,b   Di Lazzaro, V ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Critical illness; Intensive care units; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; RECOMBINANT PLASMINOGEN ACTIVATOR; WARFARIN; BIOLOGICAL MARKER;

COMPUTER ASSISTED TOMOGRAPHY; CRITICAL ILLNESS; HUMAN; HYPERTENSION; INCIDENCE; INTENSIVE CARE UNIT; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; RESUSCITATION; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; ADULT; CHILD; COMORBIDITY; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; INTENSIVE CARE; METHODOLOGY; MORTALITY; REVIEW;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHILD; COMORBIDITY; CRITICAL ILLNESS; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTENSIVE CARE; INTENSIVE CARE UNITS; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY;

EID: 67650175431     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (42)

1. Griffiths RD, Jones C. Seven lessons from 20 years of follow-up of intensive care unit survivors. Curr Opin Crit Care 2007;13:508-513 (Pubitemid 47357449)
2. Rubenfeld GD. Interventions to improve long-term outcomes after critical illness. Curr Opin Crit Care 2007;13:476-81. (Pubitemid 47357444)
3. Hopkins RO, Jackson JC. Long-term neurocognitive function after critical illness. Chest 2006;130:869-878 (Pubitemid 44423622)
4. Esteban A, Anzueto A, Alia I, Gordo F, Apezteguia C, Palizas F et al. How is mechanical ventilation employed in the intensive care unit? An international utilization review. Am J Resp Crit Care Med 2000;161:1450-1458 (Pubitemid 30329011)
5. Angus DC, Kelley MA, Schmitz RJ, White A, Popovich J, Jr. Caring for the critically ill patient. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: can we meet the requirements of an aging population? JAMA 2000;284:2762-2770
6. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-710 (Pubitemid 26254283)
7. Hough CL, Needham DM. The role of future longitudinal studies in ICU survivors: understanding determinants and pathophysiology of weakness and neuromuscular dysfunction. Curr Opin Crit Care 2007;13:489-496 (Pubitemid 47357446)
8. Angus DC, Carlet J. Surviving intensive care: a report from the 2002 Brussels Roundtable. Intensive Care Med 2003;29:368-377
9. Jordan LC, van Beek JG, Gottesman RF, Kossoff EH, Johnston MV. Ischemic stroke in children with critical illness: a poor prognostic sign. Pediatr Neurol 2007;36:244-246 (Pubitemid 46601358)
10. Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev 1959;39:183-238.
11. Stroke - 1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke 1989;20:1407-31.
12. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526
13. Gorelick PB. Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: an invited review. Stroke 2002;33:862-875 (Pubitemid 34204018)
14. Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin 2003;21:167-192
15. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003;290:2041-7. (Pubitemid 37430587)
16. Iadecola C, Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol 2001;14:89-94.
17. Emsley HC, Hopkins SJ. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008;7:341-353
18. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999;138:S419-420.
19. Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology 1991;23:118-124
20. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979 (Pubitemid 27152782)
21. Rader DJ. Inflammatory markers of coronary risk. N Engl J Med 2000;343:1179-1182
22. Wijdicks EF, Scott JP. Stroke in the medical intensive-care unit. Mayo Clin Proc 1998;73:642-646
23. Chang CJ, Chang WN, Huang LT, Chang YC, Huang SC, Hung PL et al. Cerebral infarction in perinatal and childhood bacterial meningitis. QJM 2003;96:755-762 (Pubitemid 37259365)
24. Santoro N, Giordano P, Del Vecchio GC, Guido G, Rizzari C, Varotto S et al. Ischemic stroke in children treated for acute lymphoblastic leukemia: a retrospective study. J Pediatr Hematol Oncol 2005;27:153-157 (Pubitemid 40397246)
25. Adams HP, Jr., del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-1711 (Pubitemid 46691097)
26. von Kummer R1 Allen KL, Holle R, Bozzao L, Bastianello S, Manelfe C et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997;205:327-333
27. Masuda J, Nabika T, Notsu Y. Silent stroke: pathogenesis, genetic factors and clinical implications as a risk factor. Curr Opin Neurol 2001;14:77-82. (Pubitemid 32116261)
28. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N E J Med 2003;348:1215-1222 (Pubitemid 36359297)
29. Neumann-Haefelin T, Moseley ME, Albers GW. New magnetic resonance imaging methods for cerebrovascular disease: emerging clinical applications. Ann Neurol 2000;47:559-570 (Pubitemid 30261890)
30. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-282 (Pubitemid 46138121)
31. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997;349:1569-1581 (Pubitemid 27229136)
32. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997;349:1641-1649 (Pubitemid 27234805)
33. Sever PS, Mackay JA. The hypertension trials. J Hypertens Suppl 1996;14:S29-33; discussion S33-24.
34. Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B et al. Use of ramipril in preventing stroke: double blind randomised trial. BMJ 2002;324:699-702. (Pubitemid 34259143)
35. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007;357:1301-1310 (Pubitemid 47481452)
36. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86. Erratum in: BMJ 2002;324:141. (Pubitemid 34084502)
37. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
38. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329-1339 (Pubitemid 26383772)
39. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 1993;342:1255-1262 (Pubitemid 23338782)
40. Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 1999;340:1781-1787
41. California Acute Stroke Pilot Registry (CASPR) Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology 2005;64:654-659
42. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Stroke Unit Trialists' Collaboration. BMJ 1997;314:1151-1159 (Pubitemid 27168456)